Orchestra BioMed Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OBIO research report →
About the company
Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease.
- CEO
- David Hochman
- IPO
- 2020
- Employees
- 70
- HQ
- New Hope, PA, US
Price Chart
- Market Cap
- $250.90M
- P/E
- -2.95
- P/S
- 7.67
- P/B
- 3.16
- EV/EBITDA
- -4.86
- Div Yield
- 0.00%
- Gross Margin
- 99.27%
- Op Margin
- -167.96%
- Net Margin
- -166.96%
- ROE
- -137.99%
- ROIC
- -62.63%
- Revenue
- $33.48M · 1169.22%
- Net Income
- $-52,701,000 · 13.64%
- EPS
- $-1.38 · 16.87%
- Op Income
- $-51,807,000
- FCF YoY
- 2.74%
- 52W High
- $5.42
- 52W Low
- $2.20
- 50D MA
- $4.03
- 200D MA
- $4.03
- Beta
- 0.50
- Avg Volume
- 315.18K
Get TickerSpark's AI analysis on OBIO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 1, 26 | Sherman Darren | sell | 15,000 |
| Jun 23, 26 | Fain Eric S | other | 17,327 |
| Jun 24, 26 | Fain Eric S | other | 4,261 |
| Jun 23, 26 | Fain Eric S | other | 21,277 |
| Jun 23, 26 | Pacitti David | other | 17,327 |
| Jun 24, 26 | Pacitti David | other | 3,784 |
| Jun 23, 26 | Pacitti David | other | 21,277 |
| Jun 23, 26 | Cleary Chris | other | 42,553 |
| Jun 24, 26 | Cleary Chris | other | 3,510 |
| Jun 23, 26 | Connealy Pamela Ann | other | 17,327 |
Our OBIO coverage
Recent articles, reports, and earnings notes.
No research on OBIO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OBIO report →Similar companies
Peers in the same neighborhood.